Finance

Lists
Outlook: 35.9% bullish·5.7% bearish
Go to analysis
MRK:NYSE
Merck & Co Inc
US$145,45
-0,09%
(-0,13) 1D
US$145,45
0,00% (0,00)
After hours
Closed: 12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 04 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
US$145,75
High
US$146,36
Low
US$144,64
Mkt. cap
358,85 ຕື້
Avg. vol.
9,43 ລ້ານ
Volume
6,62 ລ້ານ
Dividend
2,34%
Quarterly dividend
US$0,85
Ex-dividend date
15 ກ.ຍ. 2026
P/E ratio
116,17
52-wk high
US$156,92
52-wk low
US$82,01
EPS
US$1,25
Beta
0,21
Shares outstanding
2,47 ຕື້
No. of employees
74 ພັນ
Open
US$145,75
High
US$146,36
Low
US$144,64
Mkt. cap
358,85 ຕື້
Avg. vol.
9,43 ລ້ານ
Volume
6,62 ລ້ານ
Dividend
2,34%
Quarterly dividend
US$0,85
Ex-dividend date
15 ກ.ຍ. 2026
P/E ratio
116,17
52-wk high
US$156,92
52-wk low
US$82,01
EPS
US$1,25
Beta
0,21
Shares outstanding
2,47 ຕື້
No. of employees
74 ພັນ
News stories
From web sources and news partners
Kalkine Media
Kalkine Media
·
1 ຊົ່ວໂມງກ່ອນ
Can Merck (NYSE:MRK) Build on Its Oncology Franchise in the Period Ahead?
Yahoo Finance
Yahoo Finance
·
3 ຊົ່ວໂມງກ່ອນ
Could Merck (MRK) Have A New DME Option After Its Late Stage Trial Data?
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74 ພັນ
Founded1 ມ.ກ. 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Analyst ratings
Based on 21 analysts giving stock ratings to MRK in the past 3 months
Buy
Buy
15
Hold
6
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for MRK in the last 3 months.
Highest
Current US$145,45
US$180,00 (+23,75%)
Average
US$160,24 (+10,17%)
Lowest
US$105,00 (-27,81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Evan Seigerman
BMO Capital
Buy
Maintained
US$170,00
+16,9%
10/12/2026
Carter Gould
Cantor Fitzgerald
Hold
Maintained
US$145,00
-0,3%
10/11/2026
Daina Graybosch
Leerink Partners
Buy
Maintained
US$161,00
+10,7%
10/12/2026
Trung Huynh
RBC Capital
Hold
Reiterated
US$145,00
-0,3%
10/12/2026
Geoff Meacham
Citi
Hold
Maintained
US$145,00
-0,3%
10/12/2026
Emily Field
Barclays
Buy
Maintained
US$150,00
+3,1%
10/12/2026
Michael Yee
UBS
Buy
Maintained
US$175,00
+20,3%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
US$163,00
+12,1%
10/09/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
US$177,00
+21,7%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Maintained
US$165,00
+13,4%
10/05/2026
Asad Haider
Goldman Sachs
Buy
Maintained
US$160,00
+10%
09/30/2026
Louise Chen
Scotiabank
Buy
Maintained
US$180,00
+23,8%
09/29/2026
Steve Scala
TD Cowen
Hold
Maintained
US$155,00
+6,6%
09/22/2026
Nico Chen
DBS
Buy
Maintained
US$180,00
+23,8%
09/11/2026
Rajesh Kumar
HSBC
Buy
Maintained
US$172,00
+18,3%
09/10/2026
Vamil Divan
Guggenheim
Buy
Reiterated
US$170,00
+16,9%
09/08/2026
Courtney Breen
Bernstein
Hold
Maintained
US$105,00
-27,8%
09/07/2026
Mohit Bansal
Wells Fargo
Buy
Reiterated
US$170,00
+16,9%
09/04/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
US$170,00
+16,9%
08/24/2026
Alexandria Hammond
Wolfe Research
Buy
Maintained
US$180,00
+23,8%
08/25/2026
Luisa Hector
Berenberg Bank
Hold
Maintained
US$127,00
-12,7%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$138,00
-5,1%
05/19/2026
Unknown Analyst
Argus Research
Buy
Reiterated
US$130,00
-10,6%
05/08/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Maintained
US$179,00
+23,1%
04/17/2026
James Shin
Deutsche Bank
Buy
Upgraded
US$150,00
+3,1%
02/13/2026
Last report
4 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$-0,13 / US$-0,26
+49,43%beat
Revenue / Est. (USD)
16,61 ຕື້ / 16,37 ຕື້
+1,46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
17,28 ຕື້
16,40 ຕື້
16,29 ຕື້
16,61 ຕື້
Cost of goods sold
3,74 ຕື້
4,30 ຕື້
3,88 ຕື້
4,13 ຕື້
Cost of revenue
3,74 ຕື້
4,30 ຕື້
3,88 ຕື້
4,13 ຕື້
Research and development expenses
4,00 ຕື້
4,00 ຕື້
3,56 ຕື້
9,74 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,48 ຕື້
2,73 ຕື້
2,57 ຕື້
2,78 ຕື້
Operating expense
6,48 ຕື້
6,73 ຕື້
6,12 ຕື້
12,52 ຕື້
Total operating expenses
10,23 ຕື້
11,02 ຕື້
10,00 ຕື້
16,65 ຕື້
Operating income
7,05 ຕື້
5,38 ຕື້
6,29 ຕື້
-40,00 ລ້ານ
Other non operating income
-
41,00 ລ້ານ
42,00 ລ້ານ
59,00 ລ້ານ
EBT including unusual items
6,74 ຕື້
3,42 ຕື້
-3,53 ຕື້
-683,00 ລ້ານ
EBT excluding unusual items
6,76 ຕື້
4,98 ຕື້
5,85 ຕື້
-508,00 ລ້ານ
Income tax expense
958,00 ລ້ານ
458,00 ລ້ານ
709,00 ລ້ານ
654,00 ລ້ານ
Effective tax rate
14,20%
13,39%
-20,06%
-95,75%
Other operating expenses
-
-
-
-
Net income
5,78 ຕື້
2,96 ຕື້
-4,24 ຕື້
-1,34 ຕື້
Net profit margin
33,49%
18,07%
-26,03%
-8,04%
Earnings per share
2,58
2,04
-1,28
-0,13
Interest and investment income
96,00 ລ້ານ
69,00 ລ້ານ
35,00 ລ້ານ
35,00 ລ້ານ
Interest expense
-327,00 ລ້ານ
-411,00 ລ້ານ
-479,00 ລ້ານ
-525,00 ລ້ານ
Net interest expenses
-231,00 ລ້ານ
-342,00 ລ້ານ
-444,00 ລ້ານ
-490,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
8,15 ຕື້
6,79 ຕື້
7,69 ຕື້
1,43 ຕື້
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google